Template:Header/EKAT
From Metabolomics.JP
(Difference between revisions)
| Line 4: | Line 4: | ||
|width="10%"| [[Main_Page|トップ]] | |width="10%"| [[Main_Page|トップ]] | ||
|width="10%"| [[Volatile:ListField|class|Pharm|Class List]] | |width="10%"| [[Volatile:ListField|class|Pharm|Class List]] | ||
| − | |width="10%"| [[Volatile:ListField| | + | |width="10%"| [[Volatile:ListField|reference|Pharm|Reference List]] |
| + | |width="10%"| [[Volatile:ListField|objectives|Pharm|Objective List]] | ||
| + | |width="10%"| [[Volatile:ListField|design|Pharm|Design List]] | ||
|} | |} | ||
<small>{{Bilingual|漢方治療エビデンスレポート2010<br/>日本東洋医学会 EBM特別委員会エビデンスレポート/診療ガイドライン タスクフォース|'''Evidence Reports of Kampo Treatment 2010'''<br/>Task Force for Evidence Reports / Clinical Practice Guideline Special Committee for EBM, the Japan Society for Oriental Medicine}}</small> | <small>{{Bilingual|漢方治療エビデンスレポート2010<br/>日本東洋医学会 EBM特別委員会エビデンスレポート/診療ガイドライン タスクフォース|'''Evidence Reports of Kampo Treatment 2010'''<br/>Task Force for Evidence Reports / Clinical Practice Guideline Special Committee for EBM, the Japan Society for Oriental Medicine}}</small> | ||
</center> | </center> | ||
<hr/> | <hr/> | ||
Latest revision as of 15:26, 4 October 2011
| Menu: | トップ | Class List | Reference List | Objective List | Design List |
Evidence Reports of Kampo Treatment 2010
Task Force for Evidence Reports / Clinical Practice Guideline Special Committee for EBM, the Japan Society for Oriental Medicine
